Patient acceptability of home monitoring for neovascular age-related macular degeneration reactivation: a qualitative study

Neovascular age-related macular degeneration (nAMD) is a chronic, progressive condi-tion and the commonest cause of visual disability in older adults. This study formed part of a diag-nostic test accuracy study to quantify the ability of three index home monitoring (HM) tests (one paper-based and two digital tests) to identify reactivation in nAMD. The aim of this qualitative research was to investigate patients’ or participants’ views about acceptability and explore adher-ence to weekly HM. Semi-structured interviews were held with 78/297 participants (26%), with close family members (n=11) and with healthcare professionals involved in training participants in HM procedures (n=9) (n=98 in total). A directed thematic analytical approach was applied to the data using a deductive and inductive coding framework informed by theories of technology acceptance. Five themes emerged related to: 1. The role of HM; 2. Suitability of procedures and instruments; 3. Experience of HM; 4. Feasibility of HM in usual practice; and 5. Impediments to patient acceptability of HM. Various factors influenced acceptability including a patient’s understanding about the pur-pose of monitoring. While initial training and ongoing support were regarded as essential for over-coming unfamiliarity with use of digital technology, patients viewed HM as relatively straightfor-ward and non-burdensome. There is a need for further research about how use of performance feedback, level of support and nature of tailoring might facilitate further the implementation of routinely conducted HM. Home monitoring was acceptable to patients and they recognised its po-tential to reduce clinic visits during non-active treatment phases. Findings have implications for implementation of digital HM in the care of older people with nAMD and other long-term condi-tions.